Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians

Affiliations

• ¹ Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland; Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Clinical Pharmacology and Toxicology Division, Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine Department, Geneva University Hospitals, Geneva, Switzerland. Electronic address: Jean.terrier@hcuge.ch.
• ² Center for Research and Innovation in Clinical Pharmaceutical Sciences, University Hospital and University of Lausanne, Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Switzerland.
• ³ Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Division of Angiology and Hemostasis, Geneva University Hospitals, Geneva, Switzerland.
• ⁴ Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Clinical Pharmacology and Toxicology Division, Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine Department, Geneva University Hospitals, Geneva, Switzerland.
• ⁵ Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland; Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• ⁶ Clinical Pharmacology and Toxicology Division, Anesthesiology, Pharmacology, Intensive Care and Emergency Medicine Department, Geneva University Hospitals, Geneva, Switzerland.